# HIBSAGO
> **NDA221276** · New Drug Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 2026-10-20
## Drug
- **FDA Application Number:** NDA221276
- **Application type:** New Drug Application
- **Brand name:** HIBSAGO
- **Generic name:** Bepirovirsen
- **Active ingredients:** BEPIROVIRSEN
- **Dosage form:** INJECTION
- **Route:** SOLUTION
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE LLC
- **First approval:** 2026-10-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=221276)
---
*MORVS · CC0 1.0*